A new vaccine which has been genetically engineered by researchers at John Hopkins University, has been shown to be succesfull in "arming" the immune system to seek out and destroy cervical cancer cells. The tests have proved 90 to 100 per cent succesfull in mice, and human trials should begin soon.
Page 1 of 1
© 2013-2016 Science Photo Library Ltd. 327-329 Harrow Road, London, UK, W9 3RB
Registered in England and Wales no. 1550520. VAT no. GB 340 7410 88
Designed by Bluish